Suffolk Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-314,993
| Closed | -$1.08M | – | 133 |
|
|
2016
Q3 | $1.08M | Sell |
314,993
-126,922
| -29% | -$437K | 0.15% | 121 |
|
|
2016
Q2 | $1.54M | Buy |
441,915
+31,023
| +8% | +$108K | 0.2% | 127 |
|
|
2016
Q1 | $1.7M | Buy |
410,892
+48,995
| +14% | +$202K | 0.23% | 121 |
|
|
2015
Q4 | $1.61M | Buy |
361,897
+128,803
| +55% | +$573K | 0.2% | 128 |
|
|
2015
Q3 | $1.42M | Buy |
233,094
+25,677
| +12% | +$156K | 0.19% | 123 |
|
|
2015
Q2 | $2.46M | Buy |
207,417
+89,317
| +76% | +$1.06M | 0.29% | 111 |
|
|
2015
Q1 | $2.06M | Buy |
+118,100
| New | +$2.06M | 0.24% | 121 |
|